Marius Drug Patent Portfolio
Marius owns 1 orange book drug protected by 6 US patents Given below is the list of Marius's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12403146 | Preferred Oral Testosterone Undecanoate Therapy To Achieve Testosterone Replacement Treatment | 29 Mar, 2041 | Active |
| US11617758 | Emulsion formulations | 15 Mar, 2033 | Active |
| US12357643 | Emulsion Formulations | 15 Mar, 2033 | Active |
| US10576089 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols | 31 Dec, 2030 | Active |
| US10576090 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols | 31 Dec, 2030 | Active |
| US11590146 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols | 31 Dec, 2030 | Active |
Latest Legal Activities on Marius's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Marius.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed | 09 Sep, 2025 | US12403146 |
| Mail Patent eGrant Notification | 02 Sep, 2025 | US12403146 |
| Patent eGrant Notification | 02 Sep, 2025 | US12403146 |
| Recordation of Patent eGrant | 02 Sep, 2025 | US12403146 |
| Patent Issue Date Used in PTA Calculation | 02 Sep, 2025 | US12403146 |
| Email Notification | 02 Sep, 2025 | US12403146 |
| Email Notification | 21 Aug, 2025 | US12403146 |
| Issue Notification Mailed | 20 Aug, 2025 | US12403146 |
| Dispatch to FDC | 31 Jul, 2025 | US12403146 |
| Application Is Considered Ready for Issue | 31 Jul, 2025 | US12403146 |
| Issue Fee Payment Received | 30 Jul, 2025 | US12403146 |
| Issue Fee Payment Verified | 30 Jul, 2025 | US12403146 |
| Recordation of Patent Grant Mailed | 22 Jul, 2025 | US12357643 |
| Email Notification | 16 Jul, 2025 | US12357643 |
| Patent eGrant Notification | 15 Jul, 2025 | US12357643 |
Marius's Family Patents
Marius Drug List
Given below is the complete list of Marius's drugs and the patents protecting them.
1. Kyzatrex
Kyzatrex is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12403146 | Preferred Oral Testosterone Undecanoate Therapy To Achieve Testosterone Replacement Treatment |
29 Mar, 2041
(15 years from now)
| Active |
| US11617758 | Emulsion formulations |
15 Mar, 2033
(6 years from now)
| Active |
| US12357643 | Emulsion Formulations |
15 Mar, 2033
(6 years from now)
| Active |
| US10576089 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
31 Dec, 2030
(4 years from now)
| Active |
| US10576090 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
31 Dec, 2030
(4 years from now)
| Active |
| US11590146 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
31 Dec, 2030
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Kyzatrex's drug page